When to Refer to Cardiology for Blood Clots
Refer patients with blood clots to cardiology immediately when they have pulmonary embolism (PE) with hemodynamic instability, right ventricular dysfunction, elevated cardiac biomarkers, or clot-in-transit in the right heart chambers—these situations require urgent multidisciplinary management through a Pulmonary Embolism Response Team (PERT) that includes cardiology expertise 1, 2.
Immediate Cardiology Referral Situations
High-Risk PE (Hemodynamically Unstable)
- **Systolic blood pressure <90 mmHg** or drop ≥40 mmHg for >15 minutes
- Requires bedside transthoracic echocardiography to assess right ventricular function 1
- Cardiology involvement essential for reperfusion decisions (systemic thrombolysis, surgical embolectomy, or catheter-directed treatment) 1
Intermediate-High-Risk PE (Normotensive but Decompensating)
- Right ventricular dysfunction on imaging PLUS elevated cardiac biomarkers (troponin, BNP/NT-proBNP)
- These patients can deteriorate rapidly despite normal blood pressure 3, 4
- Cardiology should prospectively plan management strategy with contingency plans ready 1
Clot-in-Transit
- Mobile thrombus visualized in right atrium or right ventricle on echocardiography
- This is an under-recognized emergency with high mortality risk 2
- Activate PERT immediately when clot-in-transit is suspected—cardiology must be involved in deciding between aggressive anticoagulation, systemic thrombolysis, mechanical thrombectomy, or surgical embolectomy 2, 5, 3
- Recent evidence shows these patients require close bedside monitoring and rapid escalation therapy 2
Structured Referral Algorithm
Step 1: Risk Stratification at Presentation
After confirming venous thromboembolism diagnosis:
Check hemodynamic status:
- Unstable (shock/hypotension) → Immediate cardiology consult + PERT activation 1
- Stable → Proceed to Step 2
Step 2: Assess for Right Ventricular Strain
Perform echocardiography and check cardiac biomarkers:
- RV dysfunction + positive biomarkers → Urgent cardiology referral (intermediate-high-risk) 1
- RV dysfunction OR positive biomarkers alone → Cardiology consultation within 24 hours (intermediate-low-risk)
- Neither present → Low-risk, cardiology referral generally not needed unless complications arise
Step 3: Screen for Clot-in-Transit
If PE is confirmed, specifically look for mobile right heart thrombi on echocardiography:
- Present → Immediate PERT activation including cardiology 2
- Absent → Continue risk-based management
Special Situations Requiring Cardiology Input
Recurrent PE Despite Anticoagulation
- Suggests need for advanced therapies or IVC filter consideration
- Cardiology can help assess for chronic thromboembolic pulmonary hypertension (CTEPH) 1
PE with Cardiac Complications
- New atrial fibrillation, myocardial infarction (rare but reported with paradoxical embolism), or persistent right heart failure 6, 4
- These require cardiology expertise for dual management
Uncertain Cases with Cardiac Symptoms
- When PE presents mimicking acute coronary syndrome with ECG changes 4
- Cardiology involvement helps differentiate and manage appropriately
Common Pitfalls to Avoid
Don't rely solely on blood pressure to determine stability—a normotensive patient with RV strain and rising lactate is at high risk for sudden deterioration 3. The 2019 ESC Guidelines emphasize that confirmation of PE must be followed by further risk assessment beyond just hemodynamics 1.
Don't miss clot-in-transit—this finding is systematically under-recognized but dramatically changes management 2. Always specifically document its presence or absence on echocardiography.
Don't delay PERT activation in complex cases—integrated models of care with bidirectional referral pathways between specialties improve outcomes 1. Cardiology should be part of this team for intermediate-high and high-risk PE.
Routine DVT Without PE
For isolated deep vein thrombosis without pulmonary embolism and no cardiac involvement, cardiology referral is generally not indicated 7, 8, 9. These patients are managed with anticoagulation by primary care, vascular medicine, or hematology unless cardiac complications develop.